The Ascenta Therapeutics spinout has completed a series B round that will go to developing its pipeline of small-molecule treatments for cancer, hepatitis B and age-related diseases.

Existing investor Novo has taken part in a $28m round for Nerre Therapeutics, a GlaxoSmithKline spinout focusing on neuronal hypersensitivity treatments.

The automotive financing provider raised the capital in a round backed by online lending firms CreditEase and 360Jinrong, bringing its total funding to $86m.

Access Industries returned to back the cancer therapy developer's $70m series B round, having previously contributed to a $55m series A round in 2015.

The genome engineering company took its overall funding to approximately $50m in a series B round that included property developer Alexandria Real Estate Equities.

Tasly Pharmaceuticals, a major participant in the liver disease therapy developer's $55m series A round, has reinvested as part of its series B round.

Qinbaobao, operator of a platform for baby videos and photos, has raised an eight-figure amount in a series B round led by conglomerate Fosun.

The Xiaomi-backed online brokerage has secured series B funding from a range of investors including new strategic partner Citic.

HNA Group's tourism financial services spinout has raised series B+ funding from investors including H Capital, CapitaLand and Pacific Securities.